Unrelated donor bone marrow transplantation with treosulfan-based myeloablative conditioning for paroxysmal nocturnal hemoglobinuria--successful treatment despite multiple transplant-related risk factors for hemolysis including major Kidd group incompatibility

Bone Marrow Transplant. 2006 Jan;37(2):231-2. doi: 10.1038/sj.bmt.1705210.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Blood Group Incompatibility*
  • Bone Marrow Transplantation* / adverse effects
  • Busulfan / administration & dosage
  • Busulfan / analogs & derivatives
  • Hemoglobinuria, Paroxysmal / blood
  • Hemoglobinuria, Paroxysmal / complications
  • Hemoglobinuria, Paroxysmal / therapy*
  • Hemolysis
  • Histocompatibility
  • Humans
  • Kidd Blood-Group System* / blood
  • Living Donors*
  • Male
  • Risk Factors
  • Transplantation Conditioning* / methods

Substances

  • Antineoplastic Agents, Alkylating
  • Kidd Blood-Group System
  • treosulfan
  • Busulfan